Medical Policy Update Bulletin Quick View : March 2026
A bulletin listing UnitedHealthcare (UMR) medical policy and medical benefit drug policy items that were new, updated, revised, replaced, or retired with their effective dates; serves as a summary reference pointing readers to full policies for details.
Category III Codes - Status updated, effective Apr. 1, 2026.
Embolization of the Ovarian and Iliac Veins for Pelvic Congestion Syndrome - Status updated, effective Mar. 1, 2026.
Lower Extremity Endovascular Procedures - Status updated, effective Mar. 1, 2026.
Lower Extremity Endovascular Procedures - Status revised, effective May 1, 2026.
Preventive Care Services - Status revised, effective Apr. 1, 2026.
Spinal Fusion and Decompression - Status revised, effective Apr. 1, 2026.
Surgery of the Hip - Status updated, effective Mar. 1, 2026.
Surgery of the Knee - Status updated, effective Mar. 1, 2026.
Treatment of Temporomandibular Joint Disorders - Status revised, effective Mar. 1, 2026.
Vertebral Body Tethering for Scoliosis - Status revised, effective Apr. 1, 2026.
Complement C5 Inhibitors (drug policy) - Status revised, effective Apr. 1, 2026.
Denosumab (drug policy) - Status revised, effective Apr. 1, 2026.
Evkeeza (Evinacumab-Dgnb) - Status updated, effective Apr. 1, 2026.
FcRn Blockers (drug policy) - Status revised, effective Apr. 1, 2026.
Oncology Medication Clinical Coverage - Status revised, effective Apr. 1, 2026.
Ophthalmologic VEGF Inhibitors - Status revised, effective Apr. 1, 2026.
Provider Administered Drugs - Site of Care - Status revised, effective Apr. 1, 2026.
Respiratory Interleukins (Cinqair, Fasenra, & Nucala) - Status updated, effective Apr. 1, 2026.
Somatostatin Analogs - Status revised, effective Apr. 1, 2026.
Uplizna (Inebilizumab-Cdon) - Status revised, effective Apr. 1, 2026.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.